(Q51930185)

17 April 2018

title

Virtual screening for PPAR modulators using a probabilistic neural network. (English)

1 reference

17 April 2018

1 reference

5

Gisbert Schneider

1 reference

Manfred Schubert-Zsilavecz

17 April 2018

series ordinal

4

object named as

Manfred Schubert-Zsilavecz

1 reference

17 April 2018

3

Petra Schneider

1 reference

17 April 2018

author name string

Swetlana Derksen

series ordinal

1

1 reference

17 April 2018

Oliver Rau

series ordinal

2

1 reference

17 April 2018

publication date

1 December 2006

1 reference

17 April 2018

published in

ChemMedChem

1 reference

17 April 2018

volume

1

1 reference

17 April 2018

issue

12

1 reference

17 April 2018

page(s)

1346-1350

1 reference

17 April 2018

Comparison of the predicted and observed secondary structure of T4 phage lysozyme

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

Using general regression and probabilistic neural networks to predict human intestinal absorption with topological descriptors derived from two-dimensional chemical structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

Prediction of biological targets using probabilistic neural networks and atom-type descriptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

Probabilistic neural network model for the in silico evaluation of anti-HIV activity and mechanism of action.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

The mode of action of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

PPARs: therapeutic targets for metabolic disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

Roles of PPARs in health and disease.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

PPARs as drug targets to modulate inflammatory responses?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

Comparison of correlation vector methods for ligand-based similarity searching.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

On Estimation of a Probability Density Function and Mode

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

Self-Organized Formation of Topologically Correct Feature Maps

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

Prediction of Physicochemical Parameters by Atomic Contributions

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

The PPARs: from orphan receptors to drug discovery

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

Development and validation of a genetic algorithm for flexible docking

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: design, synthesis, structural biology, and molecular docking studies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

1. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands and their therapeutic utility

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activities.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

Peroxisome proliferator-activated receptor gamma as a molecular target of resveratrol-induced modulation of polyamine metabolism

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600166

7 January 2021

Identifiers

DOI

10.1002/CMDC.200600166

1 reference

17 April 2018

1 reference

17 April 2018